The collagen-stimulating effects continue developing, contributing to longer-term skin quality improvements
- March 5, 2026 - AM-PR In conjunction with Obesity Care Week, a national survey from Phenomix Sciences among medication-experienced patients found that GLP-1 outcomes, tolerability, and downstream care needs vary widely, reinforcing the need for more individualized obesity care
10.1016/j.neurobiolaging.2017.12.009 [DOI] [PubMed] [Google Scholar] Botfield H., Uldall M., Westgate C., Mitchell J., Hagen S., Gonzalez A., et al
Some GLP-1 agonists like Wegovy are approved for the treatment of obesity in those who have weight-related health conditions like high blood pressure or cholesterol
Working together with scientists and healthcare professionals, they are constantly developing and refining their products and striving to provide the best service and quality to consumers
Results may vary based on your condition and health